33 results on '"Kutikova, L"'
Search Results
2. RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category
3. PCR212 A Novel Approach to Capturing Real-World Reasons Behind Use and Satisfaction of NVX-CoV2373 Booster Use Among German Adults: Direct-to-Patient Enrollment
4. TP1 TREATMENT PATTERNS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN GERMANY
5. PCN318 CLINICAL AND TREATMENT CHARACTERISTICS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN EUROPE
6. PCN39 TREATMENT PATTERNS, MINIMAL RESIDUAL DISEASE (MRD) TESTING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A PATIENT CHART REVIEW IN BELGIUM, GREECE AND SWITZERLAND
7. AD1 - ASSOCIATION OF ADHERENCE AND TREATMENT INTENSITY WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROSIS OR OTHER CARDIOVASCULAR RISK FACTORS TREATED WITH STATINS AND/OR EZETIMIBE
8. CV4 - PATIENT AND CAREGIVER INDIRECT COSTS AFTER ACUTE CARDIOVASCULAR EVENTS IN EUROPE
9. PCV111 - Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy: A Systematic Review
10. PCV30 - The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom
11. PCV32 - Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review
12. PCV31 - Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom
13. CV1 - Interim Results of A Multi-Country Survey to Evaluate Productivity Loss and Indirect Costs after Cardiovascular Events in Europe
14. PCV111 - Healthcare Resource Utilization and Costs Associated with Cardiovascular Events In Greece: Results From A Delphi Panel
15. PCV87 - Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain
16. PCV54 - For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom
17. PHP108 - Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium
18. PRM216 - Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe
19. PCV78 - Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data
20. CV1 - The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses
21. PSY66 - Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic
22. PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
23. PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH
24. PSY25 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)
25. PIH15 ECONOMIC EVALUATION OF DARBEPOETIN ALFA (ARANESP) COMPARED TO EPOETIN ALFA (ERYPO) AND EPOETIN BETA (NEORECORMON) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA (CIA) IN AUSTRIA
26. CN8 AN ECONOMIC EVALUATION OF DASATINIB (SPRYCEL®) IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN CENTRAL AND EASTERN EUROPE
27. PCV183 - Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom
28. PIN12 THE COST-EFFECTIVENESS ANALYSIS OF ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B (CHB) PATIENTS IN POLAND
29. PCN11 COST-UTILITY ANALYSIS OF DASATINIB IN PATIENTS AFTER FIRST-LINE FAILURE OF IMATINIB IN CHRONIC MYELOID LEUKEMIA (CML) IN AUSTRIA
30. PCN41 EQ-5D IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ASSESSMENT OF VALIDITY AND RESPONSIVENESS
31. PCN12 ECONOMIC BURDEN OF PANCREATIC CANCER AND TREATMENT FAILURE
32. PCH5: HEALTHCARE EXPENDITURES ASSOCIATED WITH SEVEN TUMOR TYPES OF INTEREST (TOI) USING LARGE EMPLOYERS' CLAIMS DATABASE
33. PAR20: EFFECTIVENESS OF COMPLIANCE ON HEALTH CARE RESOURCE USE IN ASTHMA PATIENTS TREATED WITH MONTELUKAST VS. INHALED CORTICOSTEROIDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.